CN105031369A - Medicine for treating epilepsy - Google Patents
Medicine for treating epilepsy Download PDFInfo
- Publication number
- CN105031369A CN105031369A CN201510535523.0A CN201510535523A CN105031369A CN 105031369 A CN105031369 A CN 105031369A CN 201510535523 A CN201510535523 A CN 201510535523A CN 105031369 A CN105031369 A CN 105031369A
- Authority
- CN
- China
- Prior art keywords
- parts
- effects
- medicine
- rhizoma
- epilepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating epilepsy. The medicine is prepared from the following medicinal raw materials in parts by weight: 2 parts of rhizoma arisaematis, 3 parts of pinellia ternata, 3 parts of scutellaria baicalensis, 2 parts of rhizoma acori graminei, 3 parts of radix bupleuri, 4 parts of cassia twig, 3 parts of fructus aurantii immaturus, 2 parts of bamboo shaving and 2 parts of uncaria rhynchophylla. According to the medicine, rhizoma arisaematis has the effects of drying dampness, eliminating phlegm, dispelling wind and convulsion; pinellia ternata has the effects of drying dampness, eliminating phlegm, calming adverse-rising energy and relieving vomiting; scutellaria baicalensis has the effects of clearing heat, drying dampness and purging fire for removing toxin; rhizoma acori graminei has the effects of inducing resuscitation, eliminating phlegm, refreshing and reinforcing intelligence; radix bupleuri has the effects of soothing liver and promoting spleen yang; cassia twig has the effects of reinforcing yang to generate qi; fructus aurantii immaturus has the effects of eliminating phlegm and dissipating masses; bamboo shaving has the effects of clearing heat and eliminating phlegm; and uncaria rhynchophylla has the effects of calming endogenous wind and arresting convulsion. The medicinal materials are combined to achieve the effects of eliminating phlegm, dispelling wind, inducing resuscitation and calming epilepsy, and can be used for effectively treating epilepsy. Clinical experiments prove that the medicine can be used for safely and effectively treating epilepsy.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of epilepsy.
Background technology
Epilepsy is one group of clinical syndrome not normal with of short duration central nervous system function caused by cerebral neuron paradoxical discharge, has the feature of generation and recurrent exerbation suddenly.According to clinical and EEG Characteristics.Epilepsy is divided into the large class of partial seizures, Generalized seizure and unclassified epilepsy 3.
Clinical manifestation: due to the initial position of paradoxical discharge and the difference of transfer mode, the complicated clinical manifestation of epilepsy is various.Generalized tonic--Myoclonic seizures, petit mal, grand mal, myoclonic seizure, spasm, atonic seizure, simple partial seizure, complex partial seizures, secondary Generalized seizure.
The medicine of current doctor trained in Western medicine clinical treatment epilepsy mainly contains phenytoin Sodium, carbamazepine, phenobarbital, sodium valproate, ethosuximide etc.But it is long to have administration time, to gastrointestinal tract and the prejudicial shortcoming of hepatic and renal function, regularly blood drawing is needed to do hemogram biochemical analysis.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of epilepsy, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing epilepsy.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for epilepsy, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Rhizoma Arisaematis 2 parts, the Rhizoma Pinelliae 3 parts, Radix Scutellariae 3 parts, Rhizoma Acori Graminei 2 parts, Radix Bupleuri 3 parts, Ramulus Cinnamomi 4 parts, Fructus Aurantii Immaturus 3 parts, Caulis Bambusae In Taenia 2 parts, Ramulus Uncariae Cum Uncis 2 parts.
Inventor thinks: the raw wind of deficiency of the liver, spleen deficiency generating phlegm, weakness of spleen and stomach.Phlegm-fire is possessed, and causes epilepsy.So reducing phlegm, expelling pathologic wind, have one's ideas straightened out determine epilepsy carry out simultaneously ability treatment this disease.
The present invention uses: Rhizoma Arisaematis drying dampness to eliminate phlegm, expellings wind and relieving convulsion; Rhizoma Pinelliae drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI; Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication; Rhizoma Acori Graminei is had one's ideas straightened out eliminating phlegm, refreshment Fructus Alpiniae Oxyphyllae; Radix Bupleuri is soothing the liver yang invigorating; Ramulus Cinnamomi is supporing yang activating QI; Fructus Aurantii Immaturus reduces phlegm loose painful abdominal mass; Caulis Bambusae In Taenia removing heat-phlegm; Ramulus Uncariae Cum Uncis dispelling wind and relieving convulsion.All medicines share, and play reducing phlegm, expelling pathologic wind altogether, have one's ideas straightened out and determine effect of epilepsy, effectively treat epilepsy.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects epileptic 70 example for 2012 altogether between year December of December ~ 2014, all from Neurology Clinic, and 25 ~ 55 years old age, male 40 example, women 30 example.The course of disease 7 months ~ 5 years.
Diagnostic criteria:
(1) sudden, intermittent attack, companion's disturbance of consciousness, whole body or local convulsion;
(2) outbreak is regardless of occasion, can have self inflicted injury, urinary incontinence, platycoria, disappear to luminous reflectance; (3) ct or mri can specify the secondary epilepsy cause of disease.
Meet above-mentioned diagnostic criteria, the patient that the age is greater than 18 years old.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Merge serious cardiopulmonary hepatorenal disease person.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.3 months courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " epileptics diagnosis and efficacy assessment standard ".
1. control: patient does not reaccess in half a year after the treatment;
2. effective: when the frequency of patient's epilepsy is not treated, to reduce >=75%.
3. effective: when the frequency of patient's epilepsy is not treated, to reduce 50% ~ 75%.
4. invalid: when the frequency of patient's epilepsy is not treated, to reduce <50%.
3.2 therapeutic outcome
70 routine Patients' rights 27 examples, effective example 23, effective 15 examples, invalid 5 examples, total effective rate 93%.There is laxativeness in treatments period 3 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of epilepsy, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Rhizoma Arisaematis 2 grams, the Rhizoma Pinelliae 3 grams, Radix Scutellariae 3 grams, Rhizoma Acori Graminei 2 grams, Radix Bupleuri 3 grams, Ramulus Cinnamomi 4 grams, Fructus Aurantii Immaturus 3 grams, Caulis Bambusae In Taenia 2 grams, Ramulus Uncariae Cum Uncis 2 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of epilepsy.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Rhizoma Arisaematis 2 grams, the Rhizoma Pinelliae 3 grams, Radix Scutellariae 3 grams, Rhizoma Acori Graminei 2 grams, Radix Bupleuri 3 grams, Ramulus Cinnamomi 4 grams, Fructus Aurantii Immaturus 3 grams, Caulis Bambusae In Taenia 2 grams, Ramulus Uncariae Cum Uncis 2 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of epilepsy.Oral, daily once.
Embodiment 3
Take: Rhizoma Arisaematis 2 grams, the Rhizoma Pinelliae 3 grams, Radix Scutellariae 3 grams, Rhizoma Acori Graminei 2 grams, Radix Bupleuri 3 grams, Ramulus Cinnamomi 4 grams, Fructus Aurantii Immaturus 3 grams, Caulis Bambusae In Taenia 2 grams, Ramulus Uncariae Cum Uncis 2 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of epilepsy.Oral, every bu is taken for twice sooner or later.
Claims (4)
1. be used for the treatment of a medicine for epilepsy, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Rhizoma Arisaematis 2 parts, the Rhizoma Pinelliae 3 parts, Radix Scutellariae 3 parts, Rhizoma Acori Graminei 2 parts, Radix Bupleuri 3 parts, Ramulus Cinnamomi 4 parts, Fructus Aurantii Immaturus 3 parts, Caulis Bambusae In Taenia 2 parts, Ramulus Uncariae Cum Uncis 2 parts.
2. be used for the treatment of the medicine of epilepsy as claimed in claim 1, it is characterized in that, its preparation method is: take: Rhizoma Arisaematis 2 parts, the Rhizoma Pinelliae 3 parts, Radix Scutellariae 3 parts, Rhizoma Acori Graminei 2 parts, Radix Bupleuri 3 parts, Ramulus Cinnamomi 4 parts, Fructus Aurantii Immaturus 3 parts, Caulis Bambusae In Taenia 2 parts, Ramulus Uncariae Cum Uncis 2 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of epilepsy as claimed in claim 1, it is characterized in that, its preparation method is: take: Rhizoma Arisaematis 2 parts, the Rhizoma Pinelliae 3 parts, Radix Scutellariae 3 parts, Rhizoma Acori Graminei 2 parts, Radix Bupleuri 3 parts, Ramulus Cinnamomi 4 parts, Fructus Aurantii Immaturus 3 parts, Caulis Bambusae In Taenia 2 parts, Ramulus Uncariae Cum Uncis 2 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of epilepsy as claimed in claim 1, it is characterized in that, its preparation method is: take: Rhizoma Arisaematis 2 parts, the Rhizoma Pinelliae 3 parts, Radix Scutellariae 3 parts, Rhizoma Acori Graminei 2 parts, Radix Bupleuri 3 parts, Ramulus Cinnamomi 4 parts, Fructus Aurantii Immaturus 3 parts, Caulis Bambusae In Taenia 2 parts, Ramulus Uncariae Cum Uncis 2 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510535523.0A CN105031369A (en) | 2015-08-28 | 2015-08-28 | Medicine for treating epilepsy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510535523.0A CN105031369A (en) | 2015-08-28 | 2015-08-28 | Medicine for treating epilepsy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105031369A true CN105031369A (en) | 2015-11-11 |
Family
ID=54438728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510535523.0A Pending CN105031369A (en) | 2015-08-28 | 2015-08-28 | Medicine for treating epilepsy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105031369A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010095545A (en) * | 2010-02-01 | 2010-04-30 | Teikoku Seiyaku Co Ltd | Method of keeping cinnamic aldehyde content |
| CN104435800A (en) * | 2014-10-27 | 2015-03-25 | 高小娜 | Traditional Chinese medicine preparation for treating epilepsy |
-
2015
- 2015-08-28 CN CN201510535523.0A patent/CN105031369A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010095545A (en) * | 2010-02-01 | 2010-04-30 | Teikoku Seiyaku Co Ltd | Method of keeping cinnamic aldehyde content |
| CN104435800A (en) * | 2014-10-27 | 2015-03-25 | 高小娜 | Traditional Chinese medicine preparation for treating epilepsy |
Non-Patent Citations (2)
| Title |
|---|
| 朱志超: ""癫痫治验"", 《四川中医》 * |
| 盛全成: ""大柴胡汤临证新用"", 《山东中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101773650A (en) | Chinese medicinal composition for treating clonic convulsion and preparation method thereof | |
| CN103550532B (en) | Traditional Chinese medicine (TCM) composition for treating palpitation | |
| CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN102125663B (en) | Traditional Chinese medicinal preparation for treating cerebral concussion | |
| CN103007169B (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103330927B (en) | Drug for treatment of osteoarthritis | |
| CN102125678B (en) | Chinese medicinal preparation for treating hysteria disease | |
| CN102114195A (en) | Anti-drug capsule prepared from pure traditional Chinese medicines | |
| CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
| CN104000936A (en) | Traditional Chinese medicament for treating epilepsy | |
| CN105031369A (en) | Medicine for treating epilepsy | |
| CN105232913A (en) | Medicine for treating systemic lupus erythematosus | |
| CN102784235A (en) | Medicine for treating canker sores and preparation method thereof | |
| CN103285192A (en) | Traditional Chinese medicine preparation for treating epilepsy | |
| CN104606650A (en) | Traditional Chinese medicine composition treating insomnia | |
| CN103860914A (en) | Chinese medicine composition for treating epilepsy | |
| CN103690925A (en) | Traditional Chinese medicinal composition for treating amenorrhea | |
| CN102813757A (en) | Preparation method of traditional Chinese medicine for treating lumbago type acute glomerulonephritis | |
| CN102743597B (en) | Preparation method of Chinese medicine irrigation solution for treating sweating type trichomonas vaginitis | |
| CN102805851B (en) | Method for preparing traditional Chinese medicine for treating qi deficiency type acute glomerulonephritis | |
| CN103272129B (en) | Traditional Chinese medicine composition for treating neurodermatitis | |
| CN106511752A (en) | Traditional Chinese medicine composition for treating anxiety insomnia of young people | |
| CN102805850B (en) | Preparation method of traditional Chinese medicine for treating fatigue type acute glomerulonephritis | |
| CN102813897B (en) | Preparation method of traditional Chinese medicine for treating insomnia type acute glomerulonephritis | |
| CN105232662A (en) | Medicine for treating chronic colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151111 |
|
| RJ01 | Rejection of invention patent application after publication |